Eli Contorno
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: Arkansas Children's Hospital (2024–2025); Northwest Arkansas Community College (2025)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Eli Contorno's research focuses on cardiac transplantation, particularly the viability of partial heart grafts during prolonged cold preservation. This work investigates the potential for extended donor cold chain logistics, aiming to improve transplant feasibility. Contorno also studies domino partial heart transplantation, examining the suitability of infant heart transplant recipients to serve as donors. Related research includes evaluating cardiac parameters in growing piglets using transthoracic echocardiography and exploring cellular and biomechanical changes in heart valve allografts following vitrification. Other areas of investigation include options for pediatric heart valve replacement and treatment strategies for congenital heart conditions such as Tetralogy of Fallot and Pulmonary Atresia with Ventricular Septal Defect. Contorno collaborates extensively with researchers at the University of Arkansas for Medical Sciences, including Herra Javed, Brian Reemtsen, John Lowery, and Taufiek Konrad Rajab.
Metrics
- h-index: 3
- Publications: 14
- Citations: 22
Selected Publications
-
Cellular and Biomechanical Changes in Heart Valve Allografts following Vitrification (2026)Journal of the Arkansas Academy of Science OpenAlex
-
Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo (2025)
-
Treatment Strategies and Outcomes in Pulmonary Atresia With Ventricular Septal Defect Without Major Aortopulmonary Collateral Arteries in North America 2003-2023 (2025)
Collaboration Network
Top Collaborators
- Treatment Strategies and Outcomes in Pulmonary Atresia With Ventricular Septal Defect Without Major Aortopulmonary Collateral Arteries in North America 2003-2023
- Treatment Strategies and Outcomes in Pulmonary Atresia With Ventricular Septal Defect Without Major Aortopulmonary Collateral Arteries in North America 2003-2023
- Treatment Strategies and Outcomes in Pulmonary Atresia With Ventricular Septal Defect Without Major Aortopulmonary Collateral Arteries in North America 2003-2023
- Treatment Strategies and Outcomes in Pulmonary Atresia With Ventricular Septal Defect Without Major Aortopulmonary Collateral Arteries in North America 2003-2023
- Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo
- Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo
- Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo
- Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo
- Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo
- Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo
Similar Researchers
Based on overlapping research topics